Biolase inc.

Sep 14, 2023 · BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount. Dec 5, 2023 · The stock of Biolase Inc (BIOL) has seen a 30.17% increase in the past week, with a -8.48% drop in the past month, and a -63.44% decrease in the past quarter. The volatility ratio for the week is 15.60%, and the volatility levels for the past 30 days are at 10.51% for BIOL. The simple […] Apple Inc. employs 115,000 employees worldwide, with most being in the U.S. Many other jobs are attributable to Apple, including 627,000 created to support the iOS ecosystem. The company has 478 retail locations worldwide.Prior to joining BIOLASE, Brown was a co-founder of Kreativ, Inc., an international advanced dental equipment company, from 1995 until it was acquired in 1999 by Welch-Allyn, Inc., at which time he served as Director of New Product Development and Board Director for Welch-Allyn Kreativ, Inc. until 2002.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2020, and to answer questions.

FOOTHILL RANCH, Calif., May 4, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2022 financial and operating results on Thursday, May 12, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2021, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in the U.S./Canada ...BIOLASE, Inc. (NASDAQ:BIOL) issued its quarterly earnings data on Thursday, November, 9th. The medical technology company reported ($3.89) EPS for the quarter. The medical technology company earned $10.92 million during the quarter. BIOLASE had a negative trailing twelve-month return on equity of 503.34% and a negative net margin of 50.61%.

Biolase, Inc To Report Second Quarter 2022 Results On August 11, 2022. Jul 28, 2022. Report incorrect company information. Blogs. Elevating Endodontics with Dental Lasers. Jan 19, 2023. Waterlase Exclusive Trial Program: A Seamless Integration of Patient-Friendly Laser Technology.

BIOLASE, Inc. (NASDAQ:NASDAQ:BIOL) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ETCompany ParticipantsTodd Kehrli - Investor Relations, EVC...BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products.BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants. LAKE FOREST, Calif. , May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an …FOOTHILL RANCH, Calif., May 4, 2022 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it will release first quarter 2022 financial and operating results on Thursday, May 12, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. …

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 121864.

SafeAssign is an online plagiarism detection tool developed by Blackboard, Inc. It is designed to help instructors and students detect and prevent plagiarism in their academic work.

BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit is $26.00 , which reflects the issuance of the Series H Convertible Preferred Stock with an original issue discount.BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.LAKE FOREST, Calif., June 5, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), a global leader in dental lasers, is taking the necessary steps to optimize operations to capitalize on the rising ...BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 121864.BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering consisting of 16,453,569 shares of its ...

Nov 17, 2023 · BIOLASE, Inc. is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. Its proprietary systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. BIOLASE's proprietary laser products incorporate approximately 302 patented and 28 patent-pending technologies designed to provide biologically and clinically superior performance with less pain ...Apple Inc. employs 115,000 employees worldwide, with most being in the U.S. Many other jobs are attributable to Apple, including 627,000 created to support the iOS ecosystem. The company has 478 retail locations worldwide.Mar 28, 2023 · BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2022, and to answer questions. To access the live call, dial 1-888-506-0062 (U.S.) or +1 973-528-0011 (International) and provide the following code: 121864. FOOTHILL RANCH, Calif., Jan. 18, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that based on currently available information, preliminary 2022 fourth quarter revenue is expected to be between $14.0 million and $14.4 million, well above 2021 fourth quarter revenue of $12.4 …

To access the call replay, dial 1-877-481-4010 or +1 919-882-2331 (International) and enter replay passcode: 48764. About BIOLASE BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in …

Discover historical prices for BIOL stock on Yahoo Finance. View daily, weekly or monthly format back to when BIOLASE, Inc. stock was issued.May 24, 2023 · LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ... Диодный лазер. Один из новейших диодных лазеров - Epic 10, применяемых в клинике "Стоматология Лобачевых" разработан и производится в США компанией Biolase.…BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2020, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Published: November 9, 2023. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of …The U.S. Food and Drug Administration (FDA) approved Waterlase for the treatment of hard tissue in October 1998, one month before Jeffrey W. Jones was appointed ...BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.Aug 16, 2021 · BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…

IRVINE, Calif., Nov. 13, 2018 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has entered into a $12.5 million senior secured term loan agreement with SWK Funding LLC. SWK Funding LLC is a subsidiary of SWK Holdings Corporation, a Dallas, Texas-based healthcare focused investment firm.

Lincare Inc. sells oxygen and infusion systems for in-home respiratory therapy. Some of the oxygen systems include concentrators, portable and stationary liquid oxygen systems and high-pressure systems.

BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the third quarter ended September 30, 2023, and to answer questions. To access the live call, dial 1-866-682-6100 (U.S.) or +1 862-298-0702 (International) and ask to join the BIOLASE call.Intuitive Education.Biolase.com Portal Will Ensure Positive User Experience. LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and educational initiatives with the launch of its new education web portal, …Includes Net Income, Adjustments, and Cash flows from investig & financing activities. View Cash Flow. BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive….BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that …BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive…Intuitive Education.Biolase.com Portal Will Ensure Positive User Experience. LAKE FOREST, Calif., Feb. 21, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has further advanced its market awareness and educational initiatives with the launch of its new education web portal, …BIOLASE Logo (PRNewsfoto/BIOLASE, Inc.) The purchase price for one Unit was $60.00 , which reflects the issuance of the Series J Convertible Preferred Stock with an original issue discount.Jan 25, 2023 · BIOLASE REJECTS SONENDO'S "PATENTLY ABSURD" CLAIMS. FOOTHILL RANCH, Calif., Jan. 25, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL ), the world's leading dental laser company, today released ...

150 Royall St. Suite V. Canton MA 02021. Under the rights offering, BIOLASE will distribute one non-transferable subscription right for each share of common stock and each warrant issued in a private placement transaction that was consummated on June 10, 2020 (on an as-if-converted-to-common-stock basis) held on the Record Date (July 1, …BIOLASE, Inc. will host a conference call today at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and full year ended December 31, 2020, and to answer questions. For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the dial-in number in ...LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable …Instagram:https://instagram. stocks inghow much money is a brick of gold worthnsfw character ai appsvti stock chart Find international BIOLASE distributors in Italy, Russia, Bulgaria, Spain, Spain, France, Poland, Germany, Ukraine, UK, Greece, and elsewhere.Biolase, Inc. Enters into the Eleventh Amendment to Credit Agreement with SWK Funding LLC CI Nov. 09: BIOLASE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI when can you pre order iphone 15 pro maxgood solar energy stocks BIOLASE, Inc. is a medical device company that is a global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive… can i day trade on robinhood Biolase, Inc. Common Stock (BIOL) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.May 24, 2023 · LAKE FOREST, Calif., May 24, 2023 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL) ("BIOLASE" or the "Company"), a global leader in dental lasers, today announced the pricing of an underwritten public offering of 175,000 units (the "Units"), with each Unit consisting of one share of BIOLASE's Series H Convertible Redeemable Preferred Stock, par value $0.001 per share, with a liquidation preference ...